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Abstract
Introduction: This case report presents a patient with respiratory distress who went into coma and was admitted in the intensive care
unit (ICU). The paper will discuss the initial impressions in the ICU and the differential diagnosis considered to arrive at an accurate
diagnosis. It will demonstrate how information from physical therapy contributed to discern the proper diagnosis, and the evolving
treatment plan and interventions as the patient progressed and discharged out of the ICU into the hospital floors.
Methods: This is a case of a 32-year-old male who self-admitted to the emergency department (ED) of his local hospital due to shortness
of breath, weakness, and high fever. The study will detail how physical therapy helped analyze the patient’s condition to arrive at the
most appropriate management of the patient.
Results: The patient underwent 10 physical therapy sessions in the acute care setting before being transferred out to an acute
rehabilitation unit, and then discharged to home.
Discussion: This article highlights the role of physical therapy in acute care rehabilitation of a patient with a complex presentation
following a viral central nervous system (CNS) disease and its efforts in ensuring proper discharge disposition.
Keywords: viral cns infection, encephalitis, icu management, guillain-barre syndrome, critical illness polyneuromyopathy
(cipnm), acute care physical therapy, discharge planning in acute care
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Introduction
Physical therapists (PT) in acute care have seen their roles change
and evolve over the years. Physical therapy historically was
involved in mobilization, ambulation, and safety assessment of
patients in acute care, and expectations were that they will get the
patients moving enough so they can be discharged home or to the
next level of care. These interventions were usually limited by the
patients’ medical diagnosis and stability (Dubb, 2016). Physical
therapists were seen as adjunct services that assisted to improve
hospital throughput and continued availability of beds. Research
on the importance of early mobilization in various patient
populations started to change how physical therapy was utilized
in the hospitals (Falvey, 2019; Shaik, 2014). The importance of
therapeutic exercise early on to prevent deconditioning, muscle
wasting and even depression have increased the demand for
physical therapy in the acute care setting (Haider, 2019; Shaik
2014). When before, the rehab clinician will be involved close to
the time of discharge because of patient stability and tolerance,
more patients with higher acuity levels are being referred early on
and physical therapy are being entrusted with their care
(Hanekom, 2011). In the meantime, the physical therapy
profession has also evolved and made changes on entry-level
education and training, enhancing curricula, and elevating the
profession to a doctoral level with expertise on movement science
and expanded knowledge of pathophysiology and differential
diagnosis (Grignon, 2014). In spite of all these changes, the
Filipino physical therapists, along with the rest of their
international peers are still faced with underutilization and
challenges in perception as to their professional value (Al-Eisa,
2016). This highlights the need to increase collaborative
opportunities between physicians and physical therapists to
increase awareness of the roles and scope of practice of physical
therapists (Callejo-Tiuseco, 2022). The American Physical
Therapy Association (APTA) Guide in Physical Therapy practice
stated that “Physical therapists use a systematic process
(sometimes referred to as differential diagnosis) to classify an
individual into a diagnostic category. This process includes
integrating and evaluating the data that are obtained during the
examination to describe the individual condition in terms that will
guide the physical therapist in determining the prognosis and
developing a plan of care” (Guide to PT Practice. Patient and
Client Management, Diagnosis section, 3rd paragraph, 2014).
This essentially means the physical therapist can and should
synthesize any pertinent data available to them and utilize this
data to deliver the most appropriate level of care to the patient.
The acute care environment is very demanding to any clinician. It
is fast paced and exacting in its nature. Patients from the time they
are admitted are triaged according to the severity of their
condition. Due to the ever-changing conditions, clinical
presentations may not be evaluated thoroughly, and accuracy can

falter. These mistakes can occur in the best situation, without
extenuating circumstances so the risk that it can happen when time
is limited, and the urgency of the situation is of the utmost
consideration (Goldsworthy, 2017). These conditions are ever
present in the intensive care unit (ICU) (Zacharia, 2012). Medical
errors are the third leading cause of death in the United States,
resulting to as much as a quarter-of-a-million lives annually
(Garrouste-Orgeas, 2016). This incidence is of course not all due
from misdiagnosis, nor is it implied that misdiagnosis alone could
result to a fatality. The point is medical errors can happen in any
environment and it can potentially cause harm. An effective
safeguard against medical errors is the multi-disciplinary team
approach in patient management (Jeong, 2019; Kim, 2010). Each
discipline contributes their own expertise to patient management,
and also acts as another pair of expert eyes that can sound the
alarm if the clinical picture is suspect. Physical therapists with
their unique training and perspective are an important part of this
process. PTs can help assess the acutely ill patient and
competently compare their findings with the prevailing clinical
diagnosis and whether the medical treatment plan coincides with
their plan of care (Bemis-Dougherty, 2013; Falvey, 2019). This
process can identify discrepancies, and inconsistencies can be
identified and managed sooner rather than later. Critical thinking
is required and should be consistently applied throughout the
whole process.
For clinicians in the ICU the compelling dilemma is the
unconscious neurological patient. This is the type of condition that
will benefit most from a rapid assessment and intervention in
order to prevent further damage to the CNS (Goldstein, 2009).
While in the ICU, critical illness symptoms can obscure
neurological differential diagnosis leading to mismanagement and
mismatched intervention (Balin, 2012). The purpose of this case
study is to feature the differential screening process of a physical
therapist in acute care and how physical therapy intervention was
planned and changed as the patient progressed up until his
successful discharge to acute rehab.

Method
Case Description: Patient history and initial examination
Verbal consent from the participant was obtained for this case
report. This is a case of a 32-year-old male who self-admitted to
the emergency department (ED) of his local hospital due to
shortness of breath, weakness, and high fever. The ED physician
promptly diagnosed him with evolving pneumonia and admitted
him, on day one. His condition spiraled downhill very quickly,
and he was transferred to the ICU due to increasing respiratory
distress. He was given the diagnosis of acute respiratory distress
syndrome (ARDS) and soon he was intubated. Patient spent 7
days on a ventilator in the ICU before he was extubated, and on
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day 8 he found himself unable to move on his own with severe
weakness of both trunk and his extremities. The patient’s Glasgow
Coma Scale for level of consciousness at the time, as determined
by the physician was 14 out of 15, due to intermittent confusion.
His other symptoms included hyperreflexia and increased muscle
tone. Patient was given another diagnosis of critical illness
polyneuromyopathy (CIPNM). Physical therapy examined the
patient and found that his clinical assessment did not completely
fit his current diagnosis. The patient was tested in the areas of
cognition, muscle strength, sensation, postural control, and
functional mobility in addition to a neurological screening exam.
The physical therapy assessment confirmed the initial physician’s
findings, but in addition observed that the patient had significant
neurological deficits, most likely of upper motor neuron (UMN)
etiology. Table 1 summarized the physical therapy findings,
including those from other rehab disciplines. This was reported to
the attending intensivist and patient was referred to a neurologic
specialist for further testing.
Further tests and studies also ruled out other neurological
conditions that may be coincide with the patient’s current
presentation. These included his current diagnosis, CIPNM and
Guillain-Barre
Syndrome
(GBS).
Critical
illness
polyneuromyopathy is a neuromuscular cause of weakness in ICU
patients with sepsis and multi-organ failure. It is characterized as

a systemic inflammatory disease. Pathogenesis of CIPNM is
unknown with no specific toxin, infectious agents, looking at
CIPNM should also then consider the possibility of GBS (Eldar,
2014).
The consulting neurologist concluded from the various laboratory
testing and diagnostic imaging including magnetic resonance
imaging (MRI) that the patient had a viral pathology affecting his
central nervous system, viral CNS infection or encephalitis. Viral
infections in the CNS can induce neurological dysfunction and
serious life-threatening inflammatory conditions. In the United
States, viral exposure can lead to CNS infection in 4.5% of cases
and have up to an average of 26 days in the ICU
(Bookstaver,2017; Dahm, 2016). In retrospect, this patient
reported close contact with a person with flu-like symptoms a few
days before he felt ill. This diagnosis confirmed what the physical
therapy evaluation revealed and supported the therapy
interventions instituted to mitigate his deficits or nutritional
deficiency identified (Fan, 2009). The severe muscle weakness,
initial confusion, and paralysis of CIPNM patients can mimic
signs and symptoms of a neurological disorder. GBS is the most
common form of neuromuscular paralysis in developed countries.
The annual incidence of GBS in the United States is about 1-2 per
100,000 annually (Jasti, 2016; van Doorn, 2008). Its clinical
symptoms are commonly inter-related with that of CIPNM.
3
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Pharmacology
Having the diagnosis of viral CNS infection was crucial for this
patient as the pharmacological management of his condition
significantly differs from the other considered possible diagnoses.
Medications have specificity and targets the pathology that it was
designed to resolve. Drug selectivity increases its efficacy against
a particular disease while completely unremarkable for another,
or worse can be contraindicated or harmful if applied to a different
diagnosis. The timing of medication is also important, as any
delay can increase the grip of the pathogen making mitigation
more difficult or futile.
Guillain-Barre Syndrome’s standard of treatment are the use of
plasmapheresis and intravenous immunoglobulin (IVIg)
treatment (Jasti, 2016). Plasmapheresis or plasma exchange is the
process of removing antibodies and other potentially injurious
factors from the bloodstream using a cell separator. The plasma is
substituted by a different solution, usually albumin. The
remaining cells are then returned to the individual minus the
antibodies. The rationale for its use in GBS is the moderation of
the acute inflammation affecting the peripheral nerves and
manifested as a severe neuromuscular paralysis, which is thought
to be caused by an autoimmune reaction (Eldar, 2014; van Doorn,
2008). Intravenous immunoglobulin is the treatment of choice for
GBS. This is made from donated blood containing healthy
antibodies that is delivered by infusion therapy, hence halting the
individual’s own antibodies from wreaking havoc in his system.
Both therapies are delivered within a course of several days and it
is recommended to be started at the early onset of the disease
(Jasti, 2016).
Critical illness polyneuromyopathy, CIPNM is best treated by a
regimen that follows a tightened glycemic control and intensive
insulin therapy (Pati, 2008). It is thought to control inflammation
in patients at risk for or afflicted with the condition (Hermans,

2008). This approach is both for the prevention and treatment of
CIPNM. The key is to lessen the time the patient remains in crisis
or connected to a ventilator.
Viral infection in the CNS is treated by antiviral agents. These are
specific and potent agents that’s able to cross the blood-brain
barrier and neutralizes the virus before it can cause further damage
(Bookstaver, 2017). The dosage and timing of antiviral
medications are important to consider, because if applied late, the
viral load may be so high that it can overwhelm the hosts leading
to a fatal outcome. Identification of the infectious agent has to be
a priority. Anti-viral drugs can be effective on some, but not all
viruses that afflict the CNS. Left unchecked, the virus will
proliferate and wreak havoc and disrupt this sensitive neuro
environment (Terry, 2012). So, if a pharmacological intervention
is possible, it has to be applied immediately.
These differing scenarios have to be considered for this patient. If
the diagnosis is inaccurate or missed, then use of IVIg or
plasmapheresis would have been ineffective and/or attempting to
tightly control his blood glucose levels would also be
inappropriate. The consequence of attempting these ineffectual
treatments would be dire as these trials would prevent the patient
from receiving the antiviral agents in time, possibly causing
irreversible CNS damage. In a case of a viral CNS infection,
getting the accurate diagnosis early on and identifying the
pathogen (virus), will allow for treatment to start promptly,
hopefully increasing the patient’s chances of recovery.
This patient’s case evolved so fast and at dangerously precipitous
level that the medical team was forced to act quickly and
decisively. A dose of anti-viral agents was prescribed in
consideration of all the input from the members of the ICU team
(see Differential Screening section). A combination of the antiviral drugs Acyclovir and Ganciclovir were administered
intravenously for 14 days. Both anti-virals have shown more than
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promising potency in treating CNS infections (Giovane, 2018).
The principal factor is prompt action in order to prevent the
development of long-term complications and increased mortality
to the disease.
Other pertinent medications include the sedation used during the
patient’s intubation period. Sedation and analgesia are generally
recommended for patients on mechanical ventilation in the ICU.
The primary reasons were for patient comfort, prevent anxiety and
to avoid accidental extubation due to patient agitation or irritation
from the endotracheal tube and the lung pressure from the
ventilator machine (Frade-Mera, 2016). Any of the conditions can
result to patient-ventilator asynchrony, a serious disorder that can
contribute to poorer outcomes (Bruni, 2019). These safeguards
are usually important for the general well-being and safety of the
patient. However, in the backdrop of the COVID-19 pandemic,
this is also important for the health and safety of the medical staff
in the ICU. Forceful self-extubation can result to uncontrolled
release of aerosolized bodily liquids that can spread infectious
sputum all over the room. This can increase the risk of
transmission and infection to the virus. The process of

reintubation will also cause unnecessary exposure risk to
healthcare workers. In a droplet precaution environment where
heightened risk of cross-infection to a life-threatening contagion
is high-stakes, these risks need to be carefully mitigated
(Hanidziar, 2020). The patient received propofol for sedation
which is also used for intubated patients with COVID-19. The
side effects and special considerations for sedation will be
discussed in the next section.

Medication side effects: Antivirals
Antiviral medications have their own risks when used. One of the
common side effects of this class of medication is acute kidney
injury or nephrotoxicity that leads to acute renal failure (Wong,
2017). The mechanisms of which is still being debated because it
can vary depending on the drug and the individual. However, the
consequence remains serious and severe, up to the point that the
patient may require dialytic therapy (Leowattana, 2019). Table 2
summarizes some of the serious side effects of well-known
antivirals.
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As can be seen on Table 2, antivirals such as Acyclovir, can cause
acute kidney injury along with headaches, mental changes, and
bone marrow suppression. Myelosuppression or bone marrow
suppression is a serious side effect usually from chemotherapy,
wherein there is a decrease bone marrow activity and reduction in
blood cells production. If allowed unabated, this condition will
lead to severe infections and even uncontrolled hemorrhage which
can be fatal (Epstein, 2020). These side effects should be
monitored by the medical team and considered by the treating
physical therapist. Patients showing signs of nephrotoxicity may
require rest and avoid strenuous activities to help the body to

recuperate. Patients with severe electrolyte imbalance may
require aggressive hydration and need monitoring for signs and
symptoms of dehydration during physical therapy (Bookstaver,
2017). These conditions will affect the patient’s tolerance to
activities and physical therapy treatment have to be modified
accordingly. At the time of writing of this paper, there is an
ongoing public health crisis around the world, a global pandemic
caused by a coronavirus, SARS-CoV-2. The devastating effect of
this virus has been unprecedented in modern history. Remdescivir
is an antiviral drug that underwent clinical trials at the National
Institute of Health (NIH) for the treatment of COVID-19 (NIH,
6
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2020). The scientists at the NIH have recommended Remdescivir
for advanced COVID-19 cases. There is still a lot of data to be
fully analyzed, but initial reports show the drug can cause elevated
liver enzymes and possibly significant liver damage along with
other long-term unknowns (Amirian, 2020). Knowing what we
know now, will the risks still outweigh the benefits?

the need for unconsciousness with the end goal of resolving the
cardiopulmonary
problem,
and
eventually
regaining
consciousness and coherence at the soonest possible time. It is
important for the ICU staff to continually assess and monitor
patients under sedation for any signs of distress or abnormal
physiologic responses.

Side effects of sedating agents

The sedating agent used in this case was Propofol. It belongs in
the class of non-benzodiazepine lipophilic drugs that can quickly
cross the blood-brain barrier and effect sedation. Its accelerated
effect in inducing sedation is equaled by its reputation for early
recovery of consciousness once continuous infusion is
discontinued. The drug is also regarded to have neuroprotective
properties in cases of brain ischemia, which may be advantageous
for our patient with viral encephalitis (Patel, 2012). Propofol does
have its share of adverse drug reactions, ranging from
hypotension, spike in triglyceride levels, and a rare but highly
fatal infusion syndrome characterized by bradycardia, cardiac
failure, and asystole (Smuszkiewicz, 2016). As with every other
powerful drug used in the ICU, proper titration, dosing, and
monitoring is essential to avoid catastrophic complications.

Sedation and analgesia are important to address in a mechanically
intubated patient. Pain relief or pain control is an important first
step in managing tolerance in intubated patients. Once pain is
controlled by pharmaceutical means, getting the patient under
sedation is less troublesome, but in no way less complicated
(Kapp, 2020). Over sedation and under sedation have their own
complications. Over sedation can lead to symptoms of respiratory
failure, prolonged intubation, possibly delirium and thus longer
ICU stays. Inadequate sedation can result to greater patient
discomfort, anxiety and as mentioned earlier, patient-ventilator
asynchrony and hence poorer ventilatory support (Chanques,
2020, Kapp, 2020). The ICU intensivist has to carefully balance
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Differential Screening and Red Flags
The physical therapy differential screening exam findings are
summarized on Table 3. The findings from the physical therapy
assessment taken cumulatively pointed towards an upper motor
neuron disease. This input helped the medical team to rule out the
other diagnoses being considered, CIPNM and GBS. To clarify,
and referencing the exam findings in Table 3, CIPNM would’ve
been consistent for two of the impairments, speech deficit and
dysphagia. GBS would only be consistent for autonomic
dysfunction. A viral CNS infection would have the most
consistent findings. This convinced the intensivist to refer the
patient to a neurologist who confirmed the above findings and
ordered more definitive tests. Radiologic imaging is the usual first
step in the diagnostic process of a CNS pathology. Magnetic
resonance imaging (MRI) has significantly greater sensitivity for
evaluating cerebral parenchyma and is generally superior to
computed tomography (CT) for characterizing viral, fungal, and
parasitic infections of the CNS (Swinburne, 2017). More
advanced magnetic resonance (MR) techniques can also be
employed, such as MR spectroscopy which can assess metabolic

profiles of normal and pathologic brain tissues, hence useful for
detecting CNS lesions. In addition, other diagnostic techniques
that can be used is a lumbar puncture, which can identify elevated
levels of protein and lymphocytes present in the cerebrospinal
fluid, at differing concentration thresholds which can be
characteristic with a particular CNS infection. (Bookstaver,
2017). Recently, new technologies have been developed that can
assist diagnosis at the molecular level. Refinements in the
detection of viral polymerase chain reaction (PCR) has improved
the sensitivity and specificity of testing for viral CNS infections
(Moffa, 2019). Results for these tests along with the patient’s
clinical presentation led to the final diagnosis of a viral CNS
infection.
In summary, the clinical findings observed in the physical therapy
exam (refer to Table 3), served as red flags and were the catalyst
for reconsideration of the patient’s diagnosis by the medical team.
The speed in which his symptoms worsened and quickly
deteriorated was cause for alarm. Patient came in for shortness of
breath and chest congestion, which led to respiratory distress and
an ED diagnosis of rapidly evolving pneumonia necessitating ICU
8
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admission and intubation. The precipitous degradation of his
condition leading to an acute respiratory distress syndrome
(ARDS) can be indicative of a severe virulent infection (Shah &
Wunderink, 2017). Other factors to consider are the patient’s
health history, in this case having a history of asthma, and obesity
along with a sedentary lifestyle, could all be factors that can
predispose him to a pulmonary insult (Hibbert, 2012). It is worth
mentioning that the patient’s marked improvement after the
administration of the anti-viral medications, further confirmed his
diagnosis. Figure 1 shows a timeline of events that happened from
onset of symptoms to the patient’s movement through the
different levels of acute care, up to his discharge to acute rehab.

Results
Physical Therapy Evaluation, Diagnosis and Outcomes
The patient had a comprehensive physical therapy evaluation and
assessment. His status was continually assessed and reassessed
during his entire hospitalization, as he moved from the ICU to the
medical-surgical unit. Due to the patient’s history of anxiety and
depression, behavioral symptoms were monitored, and he was

followed throughout his acute stay by the social worker and
chaplain, who also provided support to his family. Figure 2
classifies the patient’s findings according to the International
Classification of Functioning, Disability and Health (ICF) Model
(WHO, 2001). An outcomes-based approach to evaluation was
adapted. These outcome measures are summarized in Table 4.
Receptive and expressive communication was measured by the
amount of times patient would follow commands. This improved
from 20% of the time to 100% for one-step commands and zero
percent to 75% for two-step commands. The level of arousal and
attention span measures were directly proportional. As the patient
sustained his aroused state from a cumulative time of 20 minutes
to 60 minutes, his attention span increased from an average of
20% to 100% of the time. Postural control exhibited by
improvement in sitting balance and time in unsupported sitting,
had a converse relationship whereas his assist level decreased
(max assist to minimal assist), his time unsupported increased
(average of 10 minutes to 25 minutes) in a 60-minute session. A
modified sitting functional reach test showed improvement from
the 5th session at 6 inches, to 12 inches at the time of discharge.
Functional mobility activities were divided by part tasks from
rolling in bed to sitting from supine, and up to attempted transfer
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activity. Mobility levels steadily improved from dependent in
most activities, changed to moderate-minimum assist, except for
sit to stand as patient still had significant axial muscle weakness.
Most importantly, his tolerance to physical therapy interventions
continued to increase. The rating of perceived exertion (RPE) was
chosen to gauge endurance as it has been found suitable for
patients with critical illness (Amidei, 2012). It was modified
accordingly due to his impaired cognition by using a visual analog
scale for patient to indicate by pointing when prompted. This
outcome measure had marked improvement, perhaps due to
patient’s own motivation to be discharged to an acute rehab
facility. One of the main criteria for a successful transition to acute
rehab is for the patient to exhibit sustained and significant
tolerance to therapy, enough to indicate that he can participate for
at least three (3) hours per day. The use of these outcome scales
afforded the treating physical therapists an objective measure to
weigh proper dosing of activity, while working within safe
treatment parameters (Johnson, 2017). Co-treatment with
occupational therapy accorded much needed patient handling
assistance, improved patient safety, and prevented over-taxing the
patient with multiple discipline visits. The hospital required the
use of the Activity Measure for Post-Acute Care (AM-PAC) “6clicks” daily activity short form as a determinant for discharge
planning and disposition (Pfoh, 2020). The patient’s AM-PAC
score increased from 6 out of 24 at initial evaluation, to a 10 out
of 24 the day before discharge showing significant potential for
improvement.

Physical Therapy Goals/Patient Goals
The physical therapy evaluation done on day 8, when patient was
extubated and 3 days before the MRI confirmed a neurological
disorder clearly showed that the findings are not consistent with
the medical diagnosis of CIPNM and points more towards a CNS
pathology. Prognosis was judged as fair, due to his age and
potential for progress, but restrained by his significant symptoms
and neurological diagnosis. A Response-dependent treatment
approach was adopted for the treatment plan. It required detailed
continuous dynamic assessment and evaluation before, during and
after each mobilization session to ensure that the intervention had
the intended effect (Amundadottir, 2018). Table 5 summarizes the
problems and PT goals as the patient progressed through the
different levels of the hospital.
These goals were quantified by the patient’s performance of
activity, time and amount of assistance needed. In addition, using
the outcome measures outlined in table 4, with functional reach
test in sitting, and the modified Borg scale for rating of perceived
exertion. The patient and family members, his wife and patient’s
mother were all involved in setting the therapy goals. Patient’s
stated goal of “walk out of the hospital”, was translated to
progressive levels of activity that will allow him to appreciate his
progress and motivate him to actively participate in the process.
His wife and mother supported his goals and were instrumental in

keeping the patient’s positive outlook and enthusiastic with
therapy. The patient completed a total of 10 physical therapy
sessions (twice on the last day) in acute care before being
discharged to the acute rehabilitation facility for continuation of
therapy services.

Discussion
The process of differential screening for acute care physical
therapists should be standard practice in every country, such as
the Philippines. Critical thinking and methodical analysis are
expectations for our profession in order to achieve best possible
outcomes for our patients. Physical therapists in the Philippines
have to consider themselves as an integral part of the medical
team, providing a unique perspective and skill set which they’re
most qualified to do.
Proper physical therapy differential diagnosis in acute care
requires a process of continual dynamic assessments. The process
should reflect the highly changeable nature of the patient’s
physiological status. It should be prompted by our sense of
professional responsibility by advocating for better patient
outcomes and quality of care (Masley, 2011). The challenge of a
complex environment such as acute care makes it more pressing
for us to use best judgment in our examinations. The processing
of information can be daunting. There are multiple diagnoses to
consider, each one has to be carefully examined and eliminated
until the clinician can arrive at the most logical finding. Physical
therapy findings have valuable information. The physical
therapist can communicate that to the medical staff as additional
consideration for their treatment choices for their patient. The
team has to remain on target, because the ramifications for a
missed diagnosis can be quite serious. In the case of this patient
the other diagnoses considered, CIPNM and GBS has medical
interventions very different from a viral CNS infection (Latronico
2011). It may cause more harm if applied inappropriately and also
equally concerning is the possible delay of an effective treatment.
In using a methodical approach, the physical therapist made it
clear that the evidence points towards the diagnosis of a viral CNS
infection.
In differentiating CIPNM and GBS, these patients do not usually
present with cognitive deficits (Latronico, 2011). In those cases,
consider possibility of delirium from sepsis, respiratory
compromise, or medication effects. Patients with CIPNM and
GBS would have more distal muscle weakness vs. axial weakness
(Cunningham, 2018). In that case, facilitation of head and trunk
extension may not be a primary consideration in the ICU. In order
to increase postural control, mass movement pattern was initially
used to facilitate axial and proximal muscle recruitment. The
transitions to upright activities provided afferent sensory feedback
to improve postural awareness. Due to the distal muscle weakness
in patients with CIPNM or GBS, treatment focus may take
advantage of axial stability to facilitate diagonal movement
10
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patterns to accomplish specific tasks. In this patient case,
facilitating weight bearing and use of upper and lower extremities
allowed initial stability in upright activities. This is built upon to
coincide with the utilization of motor learning principles of
structuring practice from part to whole task complexity to
promote acquisition and use of random practice for retention of
the learning. Additionally, CIPNM and GBS will need a more
gradual progression even more so than viral CNS infection
patients due to expected severe ICU-acquired weakness and
prolonged ventilation (Nordon-Craft, 2012). Treating this patient
in distributed practice allowed for rest and proper pacing while
fading feedback.
The examination process was limited by the lack of functional
outcome measures that are sensitive to detect changes in patients
with ICU-acquired weakness. There is a paucity of evidencebased early mobilization programs for patients with viral CNS
infections in the ICU.
Patients with viral CNS infections can be differentiated from other
critically-ill patients in the ICU, as well as from those diagnosed
with CIPNM and GBS by utilizing qualitative analysis applied to
physical therapy neurological examination and assessment. As
exemplified in this case, a response-dependent treatment
approach for critically ill patients in the ICU can lead to increased
level of consciousness, postural control, functional mobility, and
activity tolerance in this population.
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